Certolizumab pegol Recruiting Phase N/A Trials for Rheumatoid Arthritis

IndicationsStatusPurposePhase
RecruitingNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03016260RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis
NCT02778789Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers
NCT02620189Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα